Shigeru Ohta

8.7k total citations
273 papers, 7.0k citations indexed

About

Shigeru Ohta is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis and Pharmacology. According to data from OpenAlex, Shigeru Ohta has authored 273 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 51 papers in Health, Toxicology and Mutagenesis and 39 papers in Pharmacology. Recurrent topics in Shigeru Ohta's work include Pharmacogenetics and Drug Metabolism (32 papers), Effects and risks of endocrine disrupting chemicals (27 papers) and Neuroscience and Neuropharmacology Research (26 papers). Shigeru Ohta is often cited by papers focused on Pharmacogenetics and Drug Metabolism (32 papers), Effects and risks of endocrine disrupting chemicals (27 papers) and Neuroscience and Neuropharmacology Research (26 papers). Shigeru Ohta collaborates with scholars based in Japan, United States and Italy. Shigeru Ohta's co-authors include Shigeyuki Kitamura, Kazumi Sugihara, Nariaki Fujimoto, Seigo Sanoh, Yaichiro Kotake, Tomoharu Suzuki, Masaaki Hirobe, Naoto Uramaru, Norimasa Jinno and Hiroaki Kuroki and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Shigeru Ohta

268 papers receiving 6.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigeru Ohta Japan 42 1.8k 1.6k 932 869 685 273 7.0k
Giorgio Federici Italy 55 6.8k 3.7× 632 0.4× 794 0.9× 527 0.6× 947 1.4× 308 12.2k
Kenneth R. Reuhl United States 45 2.4k 1.3× 1.1k 0.6× 456 0.5× 320 0.4× 681 1.0× 141 7.6k
Howard G. Shertzer United States 46 3.5k 1.9× 1.6k 1.0× 864 0.9× 505 0.6× 497 0.7× 128 8.1k
Terrance J. Kavanagh United States 49 2.9k 1.6× 1.3k 0.8× 362 0.4× 216 0.2× 468 0.7× 174 6.9k
Menghang Xia United States 45 3.2k 1.7× 1.5k 0.9× 666 0.7× 409 0.5× 579 0.8× 231 7.6k
Alex Odermatt Switzerland 53 3.5k 1.9× 929 0.6× 900 1.0× 542 0.6× 578 0.8× 241 9.3k
Yoshito Kumagai Japan 54 5.0k 2.7× 2.3k 1.4× 529 0.6× 1.1k 1.2× 668 1.0× 283 11.0k
Dietrich Büsselberg Qatar 54 4.7k 2.6× 621 0.4× 458 0.5× 859 1.0× 1.6k 2.4× 216 11.1k
Lawrence H. Lash United States 50 2.5k 1.4× 1.5k 0.9× 848 0.9× 267 0.3× 792 1.2× 168 7.1k
Qiang Ma United States 46 5.4k 3.0× 1.5k 0.9× 796 0.9× 407 0.5× 535 0.8× 111 10.2k

Countries citing papers authored by Shigeru Ohta

Since Specialization
Citations

This map shows the geographic impact of Shigeru Ohta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeru Ohta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeru Ohta more than expected).

Fields of papers citing papers by Shigeru Ohta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeru Ohta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeru Ohta. The network helps show where Shigeru Ohta may publish in the future.

Co-authorship network of co-authors of Shigeru Ohta

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeru Ohta. A scholar is included among the top collaborators of Shigeru Ohta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeru Ohta. Shigeru Ohta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanoh, Seigo, et al.. (2023). Methylmercury Decreases AMPA Receptor Subunit GluA2 Levels in Cultured Rat Cortical Neurons. Biological and Pharmaceutical Bulletin. 46(2). 292–300.
2.
Sanoh, Seigo, et al.. (2016). Acetaminophen induces accumulation of functional rat CYP3A via polyubiquitination dysfunction. Scientific Reports. 6(1). 21373–21373. 14 indexed citations
3.
Kotake, Yaichiro, et al.. (2016). Mild MPP+ exposure impairs autophagic degradation through a novel lysosomal acidity‐independent mechanism. Journal of Neurochemistry. 139(2). 294–308. 26 indexed citations
4.
Sugihara, Kazumi, Yuki Tamura, Yoko Watanabe, et al.. (2015). Hydrolytic metabolism of phenyl and benzyl salicylates, fragrances and flavoring agents in foods, by microsomes of rat and human tissues. Food and Chemical Toxicology. 86. 116–123. 9 indexed citations
5.
Sugihara, Kazumi, Naoto Uramaru, Yoshitaka Tayama, et al.. (2013). Prediction of human metabolism of the sedative-hypnotic zaleplon using chimeric mice transplanted with human hepatocytes. Xenobiotica. 43(11). 956–962. 16 indexed citations
6.
Tayama, Yoshitaka, Kazumi Sugihara, Seigo Sanoh, et al.. (2010). Effect of Tea Beverages on Aldehyde Oxidase Activity. Drug Metabolism and Pharmacokinetics. 26(1). 94–101. 18 indexed citations
7.
Nyalendo, Carine, Hervé Sartelet, Stéphane Barrette, et al.. (2009). Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progression. BMC Cancer. 9(1). 422–422. 7 indexed citations
8.
Miura, Takuma, Eiichi Ishii, Shigeru Ohta, et al.. (2008). A Nationwide Survey of Childhood Idiopathic Thrombocytopenic Purpura in 2006. 22(5). 378–381. 2 indexed citations
9.
Shirahata, Akira, Eiichi Ishii, Haruhiko Eguchi, et al.. (2006). Consensus Guideline for Diagnosis and Treatment of Childhood Idiopathic Thrombocytopenic Purpura. International Journal of Hematology. 83(1). 29–38. 17 indexed citations
10.
Kitamura, Shigeyuki, Kazumi Sugihara, & Shigeru Ohta. (2006). Drug-Metabolizing Ability of Molybdenum Hydroxylases. Drug Metabolism and Pharmacokinetics. 21(2). 83–98. 167 indexed citations
11.
12.
Watanabe, Tsutomu, Yoichi Takaue, Yoshifumi Kawano, et al.. (2002). HLA-identical sibling peripheral blood stem cell transplantation in children and adolescents. Biology of Blood and Marrow Transplantation. 8(1). 26–31. 24 indexed citations
13.
Okuda, Katsuhiro, Yaichiro Kotake, & Shigeru Ohta. (2002). Determination method of 1-methyl-1,2,3,4-tetrahydroisoquinoline, an endogenous parkinsonism-preventing substance, by radioimmunoassay. Life Sciences. 70(24). 2871–2883. 8 indexed citations
14.
Kato, Hirofumi, et al.. (2002). Estrogen Receptor Expression and Estrogen Receptor‐independent Cytotoxic Effects of Tamoxifen on Malignant Rhabdoid Tumor Cells in vitro. Japanese Journal of Cancer Research. 93(12). 1351–1357. 8 indexed citations
16.
Kitamura, Shigeyuki, et al.. (1999). DT-Diaphorase-Like Quinone Reductase in Rat Plasma.. Biological and Pharmaceutical Bulletin. 22(8). 883–885. 5 indexed citations
17.
Suzuki, Ayako, Osamu Shirota, Yutaka Ohtsu, et al.. (1997). Direct Analysis of Methamphetamine Enantiomers in Urine by Semi-Microcolumn Liquid Chromatography with Photodiode Array Detector : Application to Forensic Analysis. 18(1). 27–30. 2 indexed citations
18.
Nakagawa, Hidehiko, Naomi Nihonmatsu, Shigeru Ohta, & Masaaki Hirobe. (1996). Effects of New Endogenous Nonprotein Amino Acids, 1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid Derivatives, on Behavior of Mice. Biochemical and Biophysical Research Communications. 225(3). 1027–1034. 10 indexed citations
19.
Watanabe, Hikari, Michihiro Tateyama, Taku Nagao, et al.. (1993). Methamphetamine antagonistic property of (+)- and (−)-4-phenyltetrahydroisoquinoline in rat anococcygeus muscle. European Journal of Pharmacology. 243(2). 155–161. 1 indexed citations
20.
Satoh, Mitsutoshi, Shigeru Ohta, Taku Nagao, et al.. (1992). Amphetamine-Antagonistic Property of 4-Phenyltetrahydroisoquinoline: Effect on Noradrenaline Release in Spinal Cord Slices.. The Japanese Journal of Pharmacology. 60(2). 121–125. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026